Literature DB >> 3985580

IgG production within the central nervous system: a critical review of proposed formulae.

A K Lefvert, H Link.   

Abstract

Demonstration of intrathecal IgG production is employed in the diagnosis of various neurological disorders. This pathological IgG fraction in cerebrospinal fluid (CSF) can be visualized directly as oligoclonal bands by electrophoresis or isoelectric focusing or can be calculated as "excess" or "synthesized" IgG according to different formulae. A comparison of the results obtained with isoelectric focusing and with five formulae showed that even though three of the formulae discriminated well between a reference population and patients with multiple sclerosis, all five gave wrong and misleading results in the presence of blood-brain barrier damage, as defined by an abnormally raised CSF/serum albumin ratio. A mathematical and statistical evaluation of the different formulae showed only those based on covariance between CSF/serum IgG and CSF/serum albumin to be valid, and these only when values of CSF/serum albumin were normal. Among the five formulae the IgG index (equal to CSF/serum IgG:CSF/serum albumin) is unique in having a comparatively small and constant maximal relative error resulting from the variation coefficients of the IgG and albumin assays. In the case of blood-brain barrier damage, there exists currently no valid procedure to calculate intrathecally produced IgG; in such instances sensitive electrophoretic or isoelectric focusing methods demonstrating oligoclonal IgG bands are most appropriate to demonstrate intrathecal IgG production.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985580     DOI: 10.1002/ana.410170105

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.

Authors:  Stefan Presslauer; Dejan Milosavljevic; Thomas Brücke; Peter Bayer; Wolfgang Hübl; Walter Hübl
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

2.  A new complement fixation test for the diagnosis of neurocysticercosis in cerebrospinal fluid.

Authors:  E Garcia; J Sotelo
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

3.  Prevalence and predictors of blood-brain barrier damage in the HAART era.

Authors:  A Calcagno; M C Alberione; A Romito; D Imperiale; V Ghisetti; S Audagnotto; F Lipani; S Raviolo; G Di Perri; S Bonora
Journal:  J Neurovirol       Date:  2014-06-28       Impact factor: 2.643

4.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results.

Authors:  D A Compston; N M Milligan; P J Hughes; J Gibbs; V McBroom; B P Morgan; A K Campbell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

5.  Selective increase in cerebrospinal fluid immunoglobulin G in a patient with Sydenham's chorea.

Authors:  R F Gledhill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

6.  Elevated cerebrospinal fluid proteins in sciatica caused by disc herniation.

Authors:  J S Skouen; J L Larsen; E Vollset; M Grønning
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

7.  Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel.

Authors:  B Estañol; H Juárez; M del C Irigoyen; D González-Barranco; T Corona
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

8.  Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.

Authors:  J Goudsmit; L G Epstein; D A Paul; H J van der Helm; G J Dawson; D M Asher; R Yanagihara; A V Wolff; C J Gibbs; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

Review 10.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.